12:06 AM ET
Earnings Call
▶ Call
Viking Therapeutics Earnings Call: Key Takeaways
Viking Therapeutics is advancing its obesity pipeline with VK2735 showing 22% weight loss at 33 weeks and promising maintenance data, while preparing for 2028 oral data.
- Call
- Nov 15, 2026, 8:30 PM ET